ARCHIVES

FDA Approves Abbott’s HER-2 DNA Probe Kit.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

October 21, 2011

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008